论文部分内容阅读
最近,波士顿咨询公司调查了35家跨国公司及中国国内制药企业高级管理层,对包括跨国公司与中国国内企业在内的制药公司受到中国入世的影响做出评估。本文为此项调查的评估报告。
Most recently, Boston Consulting surveyed 35 multinationals and top executives from China’s domestic pharmaceutical companies to assess the impact of China’s accession to the WTO on pharmaceutical companies, including multinationals and domestic Chinese companies. This article is the evaluation report of this survey.